A new trend in the pharmaceutical world is to partner with up and coming biotech companies as they try to develop drugs to address unmet medical needs. Pharmaceutical companies such as Pfizer and Johnson & Johnson have been doing it for years through their own Venture Funds. Over the past two years, other life science entities such as Merck, Novo, and Medtronic have set up their own Venture Funds as well.
Read More
CHARLOTTE, NC, March 13, 2013/Press Release: Today Harrison Hayes, a boutique innovation and strategy consulting firm, announced the launch of a second BioArbitrage fund. BioArbitrage involves earning a risk-free profit without the outlay of capital. Harrison Hayes is currently seeking a partner/investor for the fund.
Read More
Friday, March 1, 2013, by Louis Sakoda, Harrison Hayes, LLC
With the exponential increase in the general population's online presence over the last few decades, researchers have tried to capture the internet's true potential. "Netnography" is a fairly new concept that researchers are using to gain access into the minds of a widespread consumer base via cyberspace. So what exactly is Netnography? What are its advantages? Who is using it and what are they using it for? To find out, we must first understand its origins.
Read More
Harrison Hayes's Charlotte office is currently seeking experienced sales candidates. The job description is as follows:
Read More
We are looking for Business Development and Inside Sales candidates for our Manhattan, NY office located in Chelsea.
Harrison Hayes is a boutique innovation strategy firm that empowers clients by identifying, assessing and capitalizing on new market opportunities. We use unique, proprietary research methodologies to define new growth and acquisition strategies that allow clients to strengthen and expand their brands.
Read More
